Tenders Are Invited For Faricimab (Genetical Recombination) 28.8Mg 127 Vials,Satralizumab (Genetical Recombination) 120Mg 24 Vials,Ravulizumab (Genetical Recombination) 300Mg 45 Vials,Epcoritamab (Genetical Recombination) 48Mg 12 Vials

Tender Detail

93037404
345144
Self-Funded
Tenders Are Invited For Faricimab (Genetical Recombination) 28.8Mg 127 Vials,Satralizumab (Genetical Recombination) 120Mg 24 Vials,Ravulizumab (Genetical Recombination) 300Mg 45 Vials,Epcoritamab (Genetical Recombination) 48Mg 12 Vials
NCB
Asia
Asia-Pacific Economic Cooperation, APEC,G20,APAC (Asia Pacific)
14-04-2025

Work Detail

Faricimab (Genetical Recombination) 28.8Mg 127 Vials,Satralizumab (Genetical Recombination) 120Mg 24 Vials,Ravulizumab (Genetical Recombination) 300Mg 45 Vials,Epcoritamab (Genetical Recombination) 48Mg 12 Vials

Key Value

Tender Value
Refer document

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail